The Complete Mounjaro vs Wegovy Cost Comparison Guide
Why Is Mounjaro Better Than Wegovy? Understanding Treatment Mechanisms
The question of why is Mounjaro better than Wegovy ultimately depends on individual patient factors and prescriber assessment. Mounjaro (tirzepatide) works as a dual agonist, targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, whilst Wegovy (semaglutide) focuses exclusively on GLP-1 receptor activation. Both are prescription-only medicines that must be used alongside a reduced-calorie diet and increased physical activity. At EverydayMeds, we eliminate the guesswork around pricing—our transparent costs include everything you need, with no hidden consultation fees that many online pharmacies add at checkout.
Unlike competitors who charge separate assessment fees ranging from £30-£50, our pricing is all-inclusive. This transparency matters when comparing long-term treatment costs, as both medications require ongoing monthly prescriptions. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, temperature-controlled medications with complete regulatory compliance. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns with your health profile and weight management goals.
Transparent Wegovy Pricing: What's Actually Included
When patients ask why is Mounjaro better than Wegovy, cost transparency often becomes a deciding factor. Our Wegovy pricing structure includes clinical assessment, prescriber review, prescription generation, and cold-chain delivery in one clear price. Starting doses begin at £79.99 for 0.25mg (weeks 1-4), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for maintenance 2.4mg doses. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25—these prices reflect the final amount you'll pay. Bundle options provide supply convenience, such as our Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring uninterrupted treatment progression.
Many online pharmacies advertise low medication prices but add consultation fees, prescription charges, and admin costs at checkout. Our model eliminates this frustration—the price you see covers everything required for legal, safe treatment access. Express prescriber reviews are available within 24 hours for urgent orders, compared to standard 3 working days. This comprehensive pricing approach helps patients make informed decisions when weighing why is Mounjaro better than Wegovy, as both treatments require similar ongoing investment in your health journey.
Clinical Evidence: Mounjaro vs Wegovy Treatment Outcomes
Research comparing why is Mounjaro better than Wegovy shows both medications demonstrate significant efficacy in clinical trials, though direct head-to-head comparisons are limited due to different study designs. Wegovy's STEP trial programme, including the landmark study by Wilding et al., NEJM, 2021, showed approximately 15% average weight reduction at 68 weeks when used alongside lifestyle interventions. Mounjaro's SURMOUNT trials demonstrated similar effectiveness through its dual-receptor mechanism, though patients must work with prescribers to determine individual suitability.
The question of why is Mounjaro better than Wegovy cannot be answered universally, as both treatments work through different pathways and may suit different patient profiles. Wegovy's established evidence base includes cardiovascular outcome data from the SELECT trial, showing 20% reduction in major adverse cardiovascular events. Both medications require careful dose escalation and ongoing monitoring, making prescriber expertise crucial in treatment selection and management.
How Wegovy Works: The Science Behind GLP-1 Treatment
Understanding why is Mounjaro better than Wegovy requires knowledge of how each medication functions at the cellular level. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone released in your intestines after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping patients feel satisfied with smaller portions. The medication also slows gastric emptying, prolonging the feeling of fullness after meals and potentially reducing food cravings throughout the day. Unlike Mounjaro's dual-receptor approach, Wegovy focuses specifically on GLP-1 pathways, providing a well-established treatment mechanism with extensive clinical validation. This targeted approach has proven effective for many patients when combined with dietary modifications and increased physical activity as part of comprehensive weight management.
Seamless Ordering Process: From Assessment to Delivery
When comparing why is Mounjaro better than Wegovy, the accessibility of treatment often influences patient choice. Our streamlined process begins with a comprehensive 3-minute online clinical assessment, covering medical history, current medications, and treatment goals. Following submission, qualified prescribers review applications within 3 working days (or 24 hours with express service), ensuring appropriate candidate selection for this prescription-only medicine. Upon approval, medications are dispatched via next-day delivery using temperature-controlled packaging to maintain cold-chain integrity throughout transit. Our GPhC-registered pharmacy (#9012878) ensures every order meets strict pharmaceutical standards, with discrete packaging protecting patient privacy. This efficient system eliminates traditional barriers to treatment access whilst maintaining clinical safety standards essential for prescription weight management medications.
Storage and Practical Considerations: Wegovy vs Mounjaro
A key practical factor when evaluating why is Mounjaro better than Wegovy involves storage requirements and travel convenience. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer superior flexibility once removed—remaining stable at room temperature below 30°C for up to 6 weeks compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy particularly suitable for patients with frequent travel commitments or variable refrigeration access. The FlexTouch pen delivery system provides consistent, pre-measured doses throughout the mandatory escalation schedule, from initial 0.25mg through to 2.4mg maintenance dosing. Both medications require similar injection techniques and weekly administration schedules, though individual tolerance during dose escalation may vary between treatments. This practical comparison often helps patients understand treatment logistics beyond the clinical question of why is Mounjaro better than Wegovy.
Complete Cost Transparency: Why Hidden Fees Matter in Weight Management
The decision of why is Mounjaro better than Wegovy becomes clearer when patients understand total treatment investment without surprise charges. Many online pharmacies advertise attractive headline prices for weight management medications, only to add consultation fees, prescription charges, administrative costs, and delivery surcharges at checkout—sometimes increasing final costs by £40-£60 per order. This practice creates financial uncertainty for patients planning long-term treatment budgets, particularly concerning given the ongoing nature of weight management therapy.
Our transparent pricing model eliminates these concerns by including all necessary services—clinical assessment, qualified prescriber review, prescription generation, and temperature-controlled delivery—within our published prices. This approach respects patient autonomy in treatment decision-making, providing clear cost comparisons between medication options without hidden variables. When evaluating why is Mounjaro better than Wegovy, patients can focus on clinical suitability and treatment outcomes rather than deciphering complex fee structures from various pharmacy providers.
Making Your Treatment Choice: Expert Support and Transparent Pricing
Ultimately, determining why is Mounjaro better than Wegovy requires personalised medical assessment rather than universal recommendations. Both medications represent significant advances in prescription weight management, with different mechanisms of action that may suit varying patient profiles and health conditions. Our qualified prescribers evaluate individual medical histories, current medications, treatment goals, and potential contraindications to recommend the most appropriate option. Starting your journey begins with our comprehensive clinical assessment, with Wegovy available from £79.99 using code FIRST40 for new customers or DOSE25 for returning patients—prices that include everything needed for safe, legal treatment access. Contact our clinical team through https://everydaymeds.co.uk/collections/wegovy to begin your personalised weight management consultation. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment offers the best outcomes for your individual health journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
